<DOC>
	<DOCNO>NCT00475462</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness metoprolol versus conventional treatment prevention syncope recurrence child adolescent .</brief_summary>
	<brief_title>The Effectiveness Metoprolol Prevention Syncope Recurrence Children Adolescents</brief_title>
	<detailed_description>Syncope often frustrate clinical problem see pediatric patient . Most pediatric syncope benign , vasovagal syncope ( VVS ) common type syncope see child . The diagnosis VVS establish history , often confirm tilt test . A wide range drug propose VVS , β-adrenergic block agent first-line therapy . However , clinical study show conflict result term therapy effectiveness . β-blockers claim effective 60 % 100 % young patient many uncontrolled study short- long-term control study . Sheldon et al. , recent multicenter , double-blinded , placebo-controlled , randomize study adult patient , report metoprolol effective preventing VVS . To knowledge , pediatric randomize controlled trial long-term follow-up demonstrated efficacy β-blockers prevention syncope .</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Syncope , Vasovagal</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Children history syncope include least three syncopal episode per year positive headup tilt test result . Patients exclude : Other cause syncope ; Cardiovascular and/or systemic disease ; Systolic blood pressure &gt; 130 mm Hg diastolic blood pressure &gt; 90 mm Hg； History asthma , impair liver function , Ⅱ Ⅲ degrees atrioventricular block , sinus bradycardia &lt; 40 beats/min , contraindication βblockers .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Metoprolol Syncope</keyword>
</DOC>